Exane Derivatives’s WisdomTree Emerging Markets Corporate Bond Fund EMCB Stock Holding History

Exane Derivatives’s Portfolio EMCB Stock Details EMCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-589	Closed	-$41.7K	–	689
2018 Q1	$41.7K	Hold	589	–	–	0.01%	362
2017 Q4	$43K	Hold	589	–	–	0.01%	353
2017 Q3	$43K	Hold	589	–	–	0.01%	319
2017 Q2	$42.2K	Hold	589	–	–	0.01%	325
2017 Q1	$42.1K	Hold	589	–	–	0.01%	275
2016 Q4	$41K	Hold	589	–	–	0.01%	309
2016 Q3	$41.9K	Buy	+589	New	+$41.8K	0.01%	316

Other funds holding EMCB

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Exane Derivatives's EMCB Position: Q2 2018 in Review

Exane Derivatives sold out of WisdomTree Emerging Markets Corporate Bond Fund (EMCB) in Q2 2018, closing a stake of 589 shares — an estimated $41.7K sold.

Exane Derivatives first reported a position in EMCB in Q3 2016 and held it in 7 quarters. The position peaked at $43K in Q4 2017. 16 funds tracked by Wall St. Rank hold EMCB as of Q2 2018.

Exane Derivatives reported no remaining WisdomTree Emerging Markets Corporate Bond Fund position as of Q2 2018 after selling out during the quarter.
Exane Derivatives sold 589 WisdomTree Emerging Markets Corporate Bond Fund shares in Q2 2018, an estimated $41.7K.
Exane Derivatives first reported a position in WisdomTree Emerging Markets Corporate Bond Fund in Q3 2016 and held it in 7 quarters.
Exane Derivatives's WisdomTree Emerging Markets Corporate Bond Fund position peaked at $43K in Q4 2017.
16 funds tracked by Wall St. Rank held WisdomTree Emerging Markets Corporate Bond Fund as of Q2 2018.

Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.